CONNECT-HF reaches site activation goal

Congratulations to the CONNECT-HF Team for meeting their total site activation goal of 160 sites in October.

CONNECT-HF is a large-scale, pragmatic, cluster-randomized clinical trial to evaluate the effect of a customized, multifaceted, health system-level quality-improvement (QI) program compared with usual care on heart failure (HF) outcomes and HF quality-of-care metrics, led by principal investigator Adam DeVore, MD. The trial plans to enroll 7040 participants at 160 hospitals across the United States. The goal is to evaluate different ways of improving the overall quality of care available to people with heart failure, and to help them gain the greatest benefit from the treatments and health management advice they receive.

The trial began recruiting sites in April 2017.

“We are so pleased to reach our site activation goal for this study,” said DeVore. “We are learning that the changes hospitals make in CONNECT-HF can be system-wide and impact many more patients than only those in the trial, and we are excited about the potential public health impact in learning how to best manage treatment of heart failure.”

The study will follow participants for one year post discharge.


Meet a Cardi-Yack: Fredonia

Using her own personal experiences, Fredonia Williams hopes to make a difference in the CONNECT-HF study and in the lives of people recently diagnosed with heart failure. Support for patients with heart failure is extremely important and other patients who are experts by experience are well suited to provide valuable insights to both patients and doctors.

Fredonia is a patient adviser, also known as a Cardi-Yack, in the CONNECT-HF study. Fredonia has had opportunities to interact with heart patients, cardiologists, and researchers. She believes that patient input can help researchers tweak a research question with the ultimate goal of better health for all. We invite you to watch this video to hear from Fredonia on how patients can support other patients, doctors, and researchers.